EN
抗体药类似物
Research Grade Emibetuzumab
All
TD-HY196016_1.jpg
TD-HY196016_2.jpg
TD-HY196016_3.jpg
  • CatalogTD-HY196016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsLA480,LY-2875358,CAS:1365287-97-3
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Emibetuzumab


Catalog No. TD-HY196016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG4-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P08581
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names LA480,LY-2875358,CAS:1365287-97-3
Background Emibetuzumab (LY2875358) is a humanized bivalent MET antibody (IgG4 type). Emibetuzumab shows high neutralization and internalization activities, resulting in inhibition of both HGF-dependent and HGF-independent MET pathway activation and tumor growth. Emibetuzumab can be used in study of cancer.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY196016_1.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Emibetuzumab.
TD-HY196016_2.jpg
Bioactivity
 
Detects MET/c-Met/HGFR in indirect ELISAs.
TD-HY196016_3.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Emibetuzumab.